Use of adjuvant capecitabine after NACT in older pts with early stage TNBC:

- ⬆️ trend in adjuvant cape use
- pts w/ older age and those w/ more comorbidities received ⬇️ cycles
- more cycles of cape a/w better OS

#SABCS23 with the best mentor, Dr. Mariana Chavez MacGregor!

Excited to share the TROPION-Breast04 international study poster from #SABCS23 . This collaborative effort is recruiting globally, including in Brazil. Focusing on an innovative neoadjuvant approach for triple-negative BC, combining antibodydrug conjugate with immunotherapy.

2023 was an outstanding year for breast cancer research
As we start wrapping up #SABCS23 , we need to think about how to incorporate what we learned in the clinic and future research.
Looking forward to what is yet to come to improve outcomes for our patients!
OncoAlert #BCSM

Redefining sensitivity to immunotherapy ✍🏻
A bunch of biomarkers to explore 🤯
Awesome MarleenKokLab SABCS #SABCS23

Incredible experience at the #SABCS23 Honored to lead 3 spotlight presentations and a poster, shedding light on germline genetic testing, and molecular biology of germline mutation carriers with breast cancer. Huge thanks to my incredible co-authors!

Stop by Poster Session 5's row 11 to check out our qualitative data on an online mindfulness-based stress reduction intervention for anxiety management in breast cancer survivors.
Participants perceived the intervention and its format as highly beneficial.

#SABCS23
#bcsm

Very proud of UNMC College of Medicine student, Lucas Houser, for doing a fantastic job presenting our study at #SABCS23 highlighting disparities experienced by sexual minority women receiving #BreastCancer care.

University of Nebraska Medical Center Jessica Maxwell Sean Figy MD Luke Joshua Mammen MD PhD
#AllofUs #NIH

#SABCS23 Highlights w/ Hope Rugo on HR+ #breastcancer

- #NATALEE
- #MONARCH3
- #INAVO120
- #TB01

Full discussion:
- oncbrothers.com/sabcs23-rugo
- targetedonc.com/data-dialogue-…
- Also on “Oncology Brothers” podcast

#MedTwitter #OncTwitter #bcsm SABCS Targeted Oncology

《学会速報》
【乳がん】切除不能または転移性HER2陽性乳がんと診断され、「ハーセプチン＋ドセタキセル」治療を受けたことがある女性が次の治療を考える場合、「カドサイラ」治療に「ツカチニブ」の上乗せを選択することで、無増悪生存期間の延長が期待できる。〔 #SABCS23 〕
gantaisaku.net/her2climb-02/

#SABCS23 Highlights w/ Daniel Stover, MD, FASCO on HER2+ #breastcancer

- #APHINITY
- #KATHERINE
- #HER2Climb02

Full discussion:
- OncBrothers.com/sabcs23-stover
- targetedonc.com/data-dialogue-…
- Also on the “Oncology Brothers” podcast

#MedTwitter #OncTwitter #bcsm SABCS Targeted Oncology

Promising results of the combo of zanidatamab+palbo+FULV in HR+HER2+ mBC expertly hightlighted by Dr. Santiago Escrivá at #SABCS23 👏🏼👏🏼

Juanmi Cejalvo Cristina Saura @baricorcho

Updated results of KATHERINE 7-year fu:
IDFS rates: 80.8% T-DM1 vs 67.1% tras
OS rates: 89.1% T-DM1 vs 84.4% tras
CNS rec: 5% T-DM1 vs 7% tras, looking forward to COMPASS-RD results!

T-DM1 continues to show PFS and OS benefit in pts with RD HER2+ BC

#SABCS23 OncoAlert

Great education session on #CNSmets SABCS by ⭐️ panel Carey Anders Rebecca Dent Nelson Moss Chris Lascola, Helen Shih, Jeffrey Wefel! T-DXd shows activity in the CNS, needs caution as data shows risk of RN w ADC + SRS! OncoAlert Duke Cancer Sheheryar Kabraji #SABCS23

Reassuring data from the #POSITIVE trial and an international cohort supporting pregnancy after breast cancer treatment in young survivors, including BRCA1/2 carriers, beautifully presented by Hee Jeong Kim Matteo Lambertini, MD PhD and Hatem Azim. Ann Partridge MD, MPH #SABCS23

Back to reality post #SABCS23 – kicking off the week with our monday morning breast cancer unit meeting. Best team ever! Hospital Clínic

Montserrat Muñoz Mateu Maria Vidal badamo Benjamin Walbaum, MD Tomás Pascual Isabel Garcia Fructuoso Olga Martínez-Sáez Francesco Schettini, MD PhD 🇮🇹🇪🇸🇪🇺 Pablo Rivera

💥Exited to share our collaborative work in SABCS #SABCS23 César A. Rodríguez 🩺 🐾 RebecaLm IBSAL
🎯🧬Prognostic value of PIK3CAm in HR+/HER2- mBC #PIK3CAteam
🧐Check Row13-12

Money 💰 slide. All CDK inhibitors trials in MBC with OS data. Slide by Sara Tolaney SABCS #SABCS23 OncoAlert

Algorithm for metastatic Her2 disease . 2023. Upto 5 lines. I like such money 💰 slides by Sara Tolaney SABCS #SABCS23 OncoAlert

.SABCS has been a huge success this week! More than 10,000 scientists and clinicians gathered to share the most exciting findings on breast cancer research.

Take a sneak peek at the #SABCS23 exhibition hall!

Kongreden BildiriYORUM: SABCS 2023
📅12 Aralık 2023, Salı
🕖19.00 - 20.15
🎯🔗 #kanser #cancer #onkoloji #oncology #tumor #tedavi #erkenteshis #farkındaol #SanAntonio #SanAntonio Cancer #Sanantoniobreastcancer #SABCS23 #sabcs2023